<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Regenerative Medicine Guru &#187; GMPs</title>
	<atom:link href="http://regenmedguru.com/category/gmps/feed" rel="self" type="application/rss+xml" />
	<link>http://regenmedguru.com</link>
	<description>The Knowledge Portal to Help Regenerative Medicine Products Reach the Clinic Sooner</description>
	<lastBuildDate>Wed, 23 Nov 2011 21:44:04 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Human Tissues: Never Trust, Always Verify</title>
		<link>http://regenmedguru.com/human-tissues-never-trust-always-verify</link>
		<comments>http://regenmedguru.com/human-tissues-never-trust-always-verify#comments</comments>
		<pubDate>Tue, 27 Oct 2009 23:54:18 +0000</pubDate>
		<dc:creator>Darin</dc:creator>
				<category><![CDATA[]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[GMPs]]></category>
		<category><![CDATA[GTPs]]></category>
		<category><![CDATA[regenerative medicine]]></category>

		<guid isPermaLink="false">http://regenmedguru.com/?p=128</guid>
		<description><![CDATA[On October 13, 2009, the FDA posted on its website a news release from the U.S. Attorney concerning a California man who on multiple occasions falsified records related to the suitability of human tissues for clinical use.  This is unfortunately just one example of problems with those supplying human tissues.  Follow this link to the [...]


No related posts.]]></description>
		<wfw:commentRss>http://regenmedguru.com/human-tissues-never-trust-always-verify/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New FDA Proposed Rule will Impact Regenerative Medicine Products</title>
		<link>http://regenmedguru.com/new-fda-proposed-rule-regen-med</link>
		<comments>http://regenmedguru.com/new-fda-proposed-rule-regen-med#comments</comments>
		<pubDate>Fri, 02 Oct 2009 00:30:16 +0000</pubDate>
		<dc:creator>Darin</dc:creator>
				<category><![CDATA[combination product]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[GMPs]]></category>
		<category><![CDATA[QSRs]]></category>
		<category><![CDATA[regenerative medicine]]></category>

		<guid isPermaLink="false">http://regenmedguru.com/?p=98</guid>
		<description><![CDATA[For those involved in creating regenerative medicine products that combine cells with various biomaterials, such as natural or synthetic scaffolds, you should be aware that the FDA recently issued a new Proposed Rule for these types of medical products.  In regulatory speak these are &#8220;combination products&#8221; since each component can be regulated separately.  For example, [...]


No related posts.]]></description>
		<wfw:commentRss>http://regenmedguru.com/new-fda-proposed-rule-regen-med/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

